182 related articles for article (PubMed ID: 36124236)
1. Differences in mGluR5 Availability Depending on the Level of Social Avoidance in Drug-Naïve Young Patients with Major Depressive Disorder.
Kim JH; Joo YH; Son YD; Kim HK; Kim JH
Neuropsychiatr Dis Treat; 2022; 18():2041-2053. PubMed ID: 36124236
[TBL] [Abstract][Full Text] [Related]
2. In vivo metabotropic glutamate receptor 5 availability-associated functional connectivity alterations in drug-naïve young adults with major depression.
Kim JH; Joo YH; Son YD; Kim JH; Kim YK; Kim HK; Lee SY; Ido T
Eur Neuropsychopharmacol; 2019 Dec; 29(2):278-290. PubMed ID: 30553696
[TBL] [Abstract][Full Text] [Related]
3. Association between human gray matter metabotropic glutamate receptor-5 availability in vivo and white matter properties: a [
Kim SE; Joo YH; Son YD; Kim HK; Lee SY; Lee MW; Ido T; Kim JH
Brain Struct Funct; 2020 Jul; 225(6):1805-1816. PubMed ID: 32495131
[TBL] [Abstract][Full Text] [Related]
4. Functional Analysis of Brain Imaging Suggests Changes in the Availability of mGluR5 and Altered Connectivity in the Cerebral Cortex of Long-Term Abstaining Males with Alcohol Dependence: A Preliminary Study.
Joo YH; Kim JH; Kim HK; Son YD; Cumming P; Kim JH
Life (Basel); 2021 May; 11(6):. PubMed ID: 34070900
[TBL] [Abstract][Full Text] [Related]
5. Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [(11)C]ABP688 PET.
DuBois JM; Rousset OG; Rowley J; Porras-Betancourt M; Reader AJ; Labbe A; Massarweh G; Soucy JP; Rosa-Neto P; Kobayashi E
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):152-162. PubMed ID: 26290423
[TBL] [Abstract][Full Text] [Related]
6. Metabotropic Glutamate Receptor Type 5 (mGluR5) Cortical Abnormalities in Focal Cortical Dysplasia Identified In Vivo With [11C]ABP688 Positron-Emission Tomography (PET) Imaging.
DuBois JM; Rousset OG; Guiot MC; Hall JA; Reader AJ; Soucy JP; Rosa-Neto P; Kobayashi E
Cereb Cortex; 2016 Oct; 26(11):4170-4179. PubMed ID: 27578494
[TBL] [Abstract][Full Text] [Related]
7. In vivo imaging of mGluR5 changes during epileptogenesis using [11C]ABP688 PET in pilocarpine-induced epilepsy rat model.
Choi H; Kim YK; Oh SW; Im HJ; Hwang DW; Kang H; Lee B; Lee YS; Jeong JM; Kim EE; Chung JK; Lee DS
PLoS One; 2014; 9(3):e92765. PubMed ID: 24663806
[TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine- and MK-801-induced changes in glutamate levels do not affect in vivo binding of metabotropic glutamate 5 receptor radioligand 11C-ABP688 in rat brain.
Wyckhuys T; Verhaeghe J; Wyffels L; Langlois X; Schmidt M; Stroobants S; Staelens S
J Nucl Med; 2013 Nov; 54(11):1954-61. PubMed ID: 24050937
[TBL] [Abstract][Full Text] [Related]
9. In vivo hippocampal cornu ammonis 1-3 glutamatergic abnormalities are associated with temporal lobe epilepsy surgery outcomes.
Lam J; DuBois JM; Rowley J; Rousset OG; González-Otárula KA; Soucy JP; Massarweh G; Hall JA; Guiot MC; Zimmermann M; Minuzzi L; Rosa-Neto P; Kobayashi E
Epilepsia; 2021 Jul; 62(7):1559-1568. PubMed ID: 34060082
[TBL] [Abstract][Full Text] [Related]
10. In vivo metabotropic glutamate receptor type 5 abnormalities localize the epileptogenic zone in mesial temporal lobe epilepsy.
Lam J; DuBois JM; Rowley J; González-Otárula KA; Soucy JP; Massarweh G; Hall JA; Guiot MC; Rosa-Neto P; Kobayashi E
Ann Neurol; 2019 Feb; 85(2):218-228. PubMed ID: 30597619
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal Characterization of mGluR5 Using
Bertoglio D; Kosten L; Verhaeghe J; Thomae D; Wyffels L; Stroobants S; Wityak J; Dominguez C; Mrzljak L; Staelens S
J Nucl Med; 2018 Nov; 59(11):1722-1727. PubMed ID: 29794227
[TBL] [Abstract][Full Text] [Related]
12. Test-retest variability of [
Smart K; Cox SML; Nagano-Saito A; Rosa-Neto P; Leyton M; Benkelfat C
Synapse; 2018 Sep; 72(9):e22041. PubMed ID: 29935121
[TBL] [Abstract][Full Text] [Related]
13. Progression of obsessive compulsive disorder-like grooming in Sapap3 knockout mice: A longitudinal [
Glorie D; Verhaeghe J; Miranda A; Kertesz I; Wyffels L; Stroobants S; Staelens S
Neuropharmacology; 2020 Oct; 177():108160. PubMed ID: 32454126
[TBL] [Abstract][Full Text] [Related]
14. In vivo characterization of metabotropic glutamate receptor type 5 abnormalities in behavioral variant FTD.
Leuzy A; Zimmer ER; Dubois J; Pruessner J; Cooperman C; Soucy JP; Kostikov A; Schirmaccher E; Désautels R; Gauthier S; Rosa-Neto P
Brain Struct Funct; 2016 Apr; 221(3):1387-402. PubMed ID: 25596865
[TBL] [Abstract][Full Text] [Related]
15. Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [¹¹C]ABP688.
DeLorenzo C; Sovago J; Gardus J; Xu J; Yang J; Behrje R; Kumar JS; Devanand DP; Pelton GH; Mathis CA; Mason NS; Gomez-Mancilla B; Aizenstein H; Mann JJ; Parsey RV
Transl Psychiatry; 2015 Dec; 5(12):e693. PubMed ID: 26645628
[TBL] [Abstract][Full Text] [Related]
16. Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [
Esterlis I; DellaGioia N; Pietrzak RH; Matuskey D; Nabulsi N; Abdallah CG; Yang J; Pittenger C; Sanacora G; Krystal JH; Parsey RV; Carson RE; DeLorenzo C
Mol Psychiatry; 2018 Apr; 23(4):824-832. PubMed ID: 28397841
[TBL] [Abstract][Full Text] [Related]
17. In Vivo Cerebral Translocator Protein (TSPO) Binding and Its Relationship with Blood Adiponectin Levels in Treatment-Naïve Young Adults with Major Depression: A [
Joo YH; Lee MW; Son YD; Chang KA; Yaqub M; Kim HK; Cumming P; Kim JH
Biomedicines; 2021 Dec; 10(1):. PubMed ID: 35052718
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in [
Smart K; Cox SML; Scala SG; Tippler M; Jaworska N; Boivin M; Séguin JR; Benkelfat C; Leyton M
Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1179-1183. PubMed ID: 30627817
[TBL] [Abstract][Full Text] [Related]
19. Quantification of Metabotropic Glutamate Receptor 5 Availability With Both [
Glorie D; Verhaeghe J; Miranda A; De Lombaerde S; Stroobants S; Staelens S
Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Jun; 7(6):607-615. PubMed ID: 34856382
[TBL] [Abstract][Full Text] [Related]
20. Differences in Quantification of the Metabotropic Glutamate Receptor 5 Across Bipolar Disorder and Major Depressive Disorder.
Holmes SE; Asch RH; Davis MT; DellaGioia N; Pashankar N; Gallezot JD; Nabulsi N; Matuskey D; Sanacora G; Carson RE; Blumberg HP; Esterlis I
Biol Psychiatry; 2023 Jun; 93(12):1099-1107. PubMed ID: 36764853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
